Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Groen

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Anticancer Research|June 16, 1999
A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimensG J Meersma, M Bakker, H J Groen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancerG J Veldhuis, P H Willemse, D T Sleijfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic studyH J Groen, E G de Vries, W Wynendaele, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Approaches to lung cancer treatment using the CD3 x EGP-2-directed bispecific monoclonal antibody BIS-1B J Kroesen, J Nieken, D T Sleijfer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinomaJ G Kosterink, M W de Jonge, E F Smit, et al.
Anticancer Research|September 3, 1999
99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumoursM Bakker, W T van der Graaf, D A Piers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 1998
Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumorsP L Jager, E J Franssen, W Kool, et al.
British Journal of Cancer|January 1, 1997
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposideR S de Jong, N H Mulder, D R Uges, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative GroupN van Zandwijk, H J Groen, P E Postmus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative GroupP E Postmus, H Haaxma-Reiche, E F Smit, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Anticancer Research|June 16, 1999
A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimensG J Meersma, M Bakker, H J Groen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancerG J Veldhuis, P H Willemse, D T Sleijfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic studyH J Groen, E G de Vries, W Wynendaele, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Approaches to lung cancer treatment using the CD3 x EGP-2-directed bispecific monoclonal antibody BIS-1B J Kroesen, J Nieken, D T Sleijfer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinomaJ G Kosterink, M W de Jonge, E F Smit, et al.
Anticancer Research|September 3, 1999
99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumoursM Bakker, W T van der Graaf, D A Piers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 1998
Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumorsP L Jager, E J Franssen, W Kool, et al.
British Journal of Cancer|January 1, 1997
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposideR S de Jong, N H Mulder, D R Uges, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative GroupN van Zandwijk, H J Groen, P E Postmus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative GroupP E Postmus, H Haaxma-Reiche, E F Smit, et al.
Pageof 8